Effects of Neonatal Enzyme Replacement Therapy and Simvastatin Treatment on Cervical Spine Disease in Mucopolysaccharidosis I Dogs

Mucopolysaccharidosis I (MPS I) is a lysosomal storage disease characterized by deficient α-L-iduronidase activity, leading to the accumulation of poorly degraded glycosaminoglycans (GAGs). Children with MPS I exhibit high incidence of spine disease, including accelerated disc degeneration and verte...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Bone Miner Res
Auteurs principaux: Chiaro, Joseph A, O’Donnell, Patricia, Shore, Eileen M, Malhotra, Neil R, Ponder, Katherine P, Haskins, Mark E, Smith, Lachlan J
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4256138/
https://ncbi.nlm.nih.gov/pubmed/24898323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2290
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires